Product — Clinical Trials
AIXStream TrialAI™
AI-powered clinical trial intelligence built for India's trial ecosystem.
5,000+
Clinical trials per year in India
$5.8B
Medidata acquisition price
0
India-native trial AI platforms
2nd
Largest trial market globally
The Problem
India conducts 5,000+ clinical trials per year — the second-largest market after the US. Yet the entire ecosystem depends on US platforms (Medidata acquired for $5.8B, Veeva at $2.4B revenue) at premium pricing.
Our Solution
AIXStream TrialAI provides India-native AI for patient matching, protocol analysis, site selection, and adverse event prediction — at a fraction of the cost of US platforms.
Key Features
→Automated patient-trial matching from EHR data
→Protocol document AI analysis
→Site selection optimization for Indian hospitals
→Adverse event prediction from historical data
→CDSCO regulatory document automation
→Multilingual patient consent management
→Real-time trial monitoring dashboard
→CRO and pharma company integration
Technology
NLPLangChainRAGGPT-4oClinical NERFastAPICDSCO APIs